These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences. Sandlund JT, Neckers LM, Schneller HE, Woodruff LS, Magrath IT. Cancer Res; 1993 Jan 01; 53(1):127-32. PubMed ID: 8416737 [Abstract] [Full Text] [Related]
3. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Kluiver J, Haralambieva E, de Jong D, Blokzijl T, Jacobs S, Kroesen BJ, Poppema S, van den Berg A. Genes Chromosomes Cancer; 2006 Feb 01; 45(2):147-53. PubMed ID: 16235244 [Abstract] [Full Text] [Related]
4. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ. Cancer Res; 2007 Oct 15; 67(20):9762-70. PubMed ID: 17942906 [Abstract] [Full Text] [Related]
5. Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation. De Falco G, Ambrosio MR, Fuligni F, Onnis A, Bellan C, Rocca BJ, Navari M, Etebari M, Mundo L, Gazaneo S, Facchetti F, Pileri SA, Leoncini L, Piccaluga PP. BMC Cancer; 2015 Oct 09; 15():668. PubMed ID: 26453442 [Abstract] [Full Text] [Related]
8. Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions. Haralambieva E, Schuuring E, Rosati S, van Noesel C, Jansen P, Appel I, Guikema J, Wabinga H, Bleggi-Torres LF, Lam K, van den Berg E, Mellink C, van Zelderen-Bhola S, Kluin P. Genes Chromosomes Cancer; 2004 May 09; 40(1):10-8. PubMed ID: 15034863 [Abstract] [Full Text] [Related]
10. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T. Cancer Res; 2008 Jun 01; 68(11):4123-32. PubMed ID: 18519671 [Abstract] [Full Text] [Related]
16. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift. Strobl LJ, Kohlhuber F, Mautner J, Polack A, Eick D. Oncogene; 1993 Jun 15; 8(6):1437-47. PubMed ID: 8502472 [Abstract] [Full Text] [Related]
17. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Kluiver J, van den Berg A, de Jong D, Blokzijl T, Harms G, Bouwman E, Jacobs S, Poppema S, Kroesen BJ. Oncogene; 2007 May 31; 26(26):3769-76. PubMed ID: 17173072 [Abstract] [Full Text] [Related]